Revenue segments as reported by the company.

Premiums

Products

Services

Investment and other income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Medical costs

Operating costs

Depreciation and amortization

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

UnitedHealth Group

Optum is a Health Services platform. It is a leading information and technology-enabled health services business dedicated to modernizing the system and improving the health of people and communities.

Optum

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Minnetonka, MN.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

UnitedHealth Group reports strong Q4 earnings and growth opportunities

UnitedHealth Group's Q4 2022 Earnings Call highlighted strong financial performance, growth initiatives, and confidence in sustainable earnings growth. The company is focused on enhancing consumer experiences, expanding value-based care, and driving growth through strategic investments and M&A priorities. Challenges include managing cost impacts from flu and respiratory issues, while opportunities lie in continued growth in key segments and strategic M&A.

UnitedHealth Group reports robust Q1 earnings, eyes growth opportunities

UnitedHealth Group's strong performance in Q1 2023 reflects growth across its segments, driven by a focus on value-based care and consumer-centric initiatives. While challenges exist with potential Medicare Advantage model changes, the company remains optimistic about sustained growth and opportunities for expansion.

UnitedHealth Group posts robust Q2 earnings, eyes tech-driven growth

UnitedHealth Group delivered strong financial performance in Q2 2023, with a focus on expanding patient care, driving cost efficiencies, and responding to changing healthcare dynamics. Challenges include margin pressures and managing investment gains unpredictability. Opportunities lie in leveraging technology for cost reduction and enhancing care capabilities post acquisitions.

UnitedHealth Group reports robust Q3 growth, eyes expansion in value-based care

UnitedHealth Group's Q3 performance showcased robust revenue growth and strengthened earnings outlook. The company's focus on value-based care, strong performance in pharmacy services, and investments in home care present opportunities for future growth. However, challenges related to wage inflation and margin impact at Optum Health require attention.

UnitedHealth Group posts strong 2023 results, eyes growth opportunities

UnitedHealth Group's 2023 performance showcased robust financial results, strategic investments in digital engagement, and a focus on improving healthcare quality and accessibility. While facing challenges in cost trends and industry dynamics, the company remains optimistic about its competitive positioning and growth prospects in 2024.

UnitedHealth Group resilient post-cyberattack, eyes growth opportunities

UnitedHealth Group navigated cyberattack impacts while maintaining outlook.
Strong response to challenges, focusing on growth and customer support.
Balanced approach to capital deployment and confidence in future opportunities.
Optimism in controlling costs and driving growth through innovation.

UnitedHealth Group reports resilient growth amidst cyberattack challenges

UnitedHealth Group's Q2 2024 performance reflects resilience and growth potential despite challenges from a cyberattack and other disruptions.
The company's strengths in customer recognition, Medicare Advantage programs, and technology innovation position it well for future success and market expansion.
While facing challenges like cyberattack impacts and medical care ratio issues, UnitedHealth Group remains focused on opportunities for growth and returning to baseline performance in 2025.

UnitedHealth Group affirms growth outlook amidst challenges, eyes 2025 strategy

UnitedHealth Group's Q3 2024 performance reflects strong revenue growth and a commitment to value-based care and innovation. Despite challenges like cyberattacks and care patterns impacting earnings outlook, the company remains focused on long-term growth objectives. UNH's strategic investments, focus on consumer experience, and capital deployment priorities signal a proactive approach to driving future growth.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

UnitedHealth (UNH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

UnitedHealth Group Incorporated (UNH) is Attracting Investor Attention: Here is What You Should Know

On October 15, UnitedHealth Group published financial results for the third quarter of 2024, which surprised me primarily due to the sharp increase in Optum Rx revenue. Optum Rx's revenue reached about $34.2 billion in the third quarter of 2024, up 18.5% year-on-year. Overall, due to year-over-year revenue growth in UnitedHealth Group's two main divisions, Optum and UnitedHealthcare, it repurchased shares worth $1.7 billion in Q3 2024.

UnitedHealth Group: Buy This Bargain Before It's Gone

Cheniere Energy

Western Gas Partners

This year has been profitable for many investors, with major assets like gold and the S&P 500 showing significant gains despite challenges in the market. Valuations are becoming a concern as prices rise, making it harder to find attractive investment opportunities compared to earlier in the year. Despite these challenges, I remain committed to acquiring undervalued dividend stocks and exploring high-quality options for long-term growth.

Market Bargains: 3 Dividend Stocks With Double-Digit Return Potential

Looking ahead to 2025, UNH projects adjusted earnings to reach around $30 per share at the top end, which falls short of the Zacks Consensus Estimate.

Beyond UnitedHealth's Q3 Earnings: Time to Reevaluate & Sell Stock?

Apple

Dow stocks to watch in the stock market right now.

Good Stocks To Buy Now? 2 Dow Jones Stocks To Know

Costco

General Mills

Intuitive Surgical

Tesla

Buying oversold stocks is not a question of one man's trash being another's treasure. In many cases, it's simply the ability to look at specific fundamental or technical indicators as a way to identify stocks that are buying opportunities.

Oversold But Ready to Rally: 5 Stocks to Watch Now

The market has over-reacted to UNH's cautious FY2025 guidance, since the lower bottom-line is attributed to "CMS payment cuts, the IRA, and a mismatch between Medicaid rates and medical program." Given the recently released Star rating for 2025, we believe that the redeterminations and higher medical costs may be a new normal across the health care provider industry. For now, UNH has attempted to optimize its operations while managing the Optum therapy/ drug costs, resulting in the segment's growing profit margins and decent FY2024 guidance.

UnitedHealth: Expect A New Normal In CMS Funding - Maintain Buy

UnitedHealth Group's UNH stock price pulled back following the Q3 earnings release in what can best be described as a temper tantrum. The results weren't bad, outpacing the consensus estimates and compounded by solid guidance, but the market wanted more, so it sold off.

UnitedHealth Group Pulls Back Into A Healthy Buying Opportunity

Elevance Health Inc

Despite a disappointing Q3 report, Elevance Health remains attractive due to its relatively favorable valuation compared to UnitedHealth Group and a total shareholder yield of roughly 3.5%. Elevance's expansion into healthcare services through Carelon and continued strength in Medicare and Medicaid markets support long-term growth, especially given the industry's demographic tailwinds. Though 2024 is a “reset” year, Elevance management's outlook for 2025 and beyond points to strong potential margin recovery and continued earnings growth.

Elevance Health: Why Invest Over UnitedHealth Group?

Cigna

Humana

Molina Healthcare

The Medical-HMO industry is aided by rising health insurance premiums and strategic M&A moves, but faces margin pressure from high-tech costs and staffing shortages. UNH, CI, HUM and MOH are likely to navigate industry storms.

4 HMO Stocks to Watch Despite Continued Industry Headwinds

UnitedHealth Group (NYSE: UNH) recently reported its Q3 results, with revenues and earnings exceeding our expectations. The company reported revenue of $100.8 billion and adjusted earnings of $7.15 per share, compared to our estimates of $99 billion and $6.95, respectively.

Should You Pick UNH Stock At $560?

UnitedHealth Group's NYSE: UNH stock price pulled back following the Q3 earnings release in what can best be described as a temper tantrum. The results weren't bad, outpacing the consensus estimates and compounded by solid guidance, but the market wanted more, so it sold off.

UnitedHealth Group Pulls Back Into a Healthy Buying Opportunity

UnitedHealth Group Inc UNH reported on Tuesday upbeat earnings for its third quarter.

Why 5 Of 6 UnitedHealth Analysts Are Cutting Forecasts After Q3 Earnings Release

UnitedHealth's Q3 earnings, released yesterday, revealed significant challenges, including rising healthcare costs and reduced rate increases, impacting profitability and leading to an 8% stock drop. Medicare Advantage headwinds and increased medical benefit ratios are squeezing margins, making the business less profitable than a year ago. The company has struggled with implementing value-based care, which was supposed to reduce costs but hasn't yet delivered the expected savings.

UnitedHealth Q3 Earnings Review: Deserved Sell-Off Is Not A 'Buy The Dip' Opportunity (Rating Downgrade)

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

Brokers Suggest Investing in UnitedHealth (UNH): Read This Before Placing a Bet

UnitedHealth Group's stock fell 8.1% despite beating Q3 estimates due to conservative 2024 and 2025 EPS guidance. However, I rate it as a Buy. The company's long-term EPS growth target of 13-16% is achievable, supported by the company's strong track record. UNH's current valuation is attractive, trading at a P/E ratio that aligns with historical trends, suggesting potential for double-digit annual returns based on expected EPS growth.

UnitedHealth Stock Plunges After Earnings, But It's A Buy Now

While the main indexes ended in the red, Walgreens Boots Alliance had its best day since 2008.

Stock Market Today: UnitedHealth Selloff Drags on Dow

UnitedHealth Group reported increased revenue, but also noted some cyberattack challenges that ended up affecting full-year guidance.

UnitedHealth Q3 EPS, Costs Both Rise

UNH's third-quarter earnings benefit on the back of client wins in the Optum Rx sub-unit, partly offset by an elevated operating expense level.

UnitedHealth Q3 Earnings Beat on Domestic Commercial Business

Shares of UnitedHealth Group (UNH) tumbled Tuesday after the company lowered its full-year profit outlook to reflect the impact of a cyberattack against its Change Healthcare division in February.

UnitedHealth Stock Slides as Cyberattack Continues To Affect Outlook

UnitedHealth Group Incorporated (NYSE:UNH ) Q3 2024 Earnings Conference Call October 15, 2024 8:45 AM ET Company Participants Andrew Witty - CEO John Rex - President and CFO Tim Noel - CEO, UnitedHealthcare Medicare & Retirement Amar Desai - CEO, Optum Health Roger Connor - CEO, Optum Insight Brian Thompson - CEO, UnitedHealthcare Heather Cianfrocco - CEO, Optum Dan Kueter - CEO, UnitedHealthcare of Employer & Individual Patrick Conway - CEO OptumRx Conference Call Participants Lisa Gill - JPMorgan A.J. Rice - UBS Stephen Baxter - Wells Fargo Josh Raskin - Nephron Research Scott Fidel - Stephens Justin Lake - Wolfe Research Sarah James - Cantor Fitzgerald Lance Wilkes - Bernstein Erin Wright - Morgan Stanley Andrew Mok - Barclays Operator Good morning, and welcome to the UnitedHealth Group's Third Quarter 2024 Earnings Conference Call.

UnitedHealth Group Incorporated (UNH) Q3 2024 Earnings Call Transcript

Cyberattacks can have a deceptively longtail impact, as UnitedHealth's Tuesday (Oct. 15) earnings call revealed. In February 2024, UnitedHealth Group Inc.'s Change Healthcare unit suffered a far-reaching cyberattack.

UnitedHealth Commits to ‘Consumerization' While Managing February's Ransomware Fallout

Medical costs continue to surge more than expected for health insurers.

UnitedHealth Delivered a Beat---Here's Why the Stock Plunged Anyway

While the top- and bottom-line numbers for UnitedHealth (UNH) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Compared to Estimates, UnitedHealth (UNH) Q3 Earnings: A Look at Key Metrics

The company estimates that its formal guidance for 2025 will top out at about $30 in earnings per share

News for UnitedHealth Group Stock (UNH)